Grok 4.20 Multi-Agent Beta is cheaper than Claude 3.7 Thinking Sonnet at $2/M vs $6/M input tokens.
Whole landing page for a startup that reads your face. It renders or it doesn't.
Which answer wins?
Three-month biohacker protocol, with dosages and biomarkers named.
Claude 3.7 Thinking Sonnet: Comprehensive 3-Month Longevity Optimization Protocol Initial Assessment Phase (Week 0) Establish your baseline with these measurements before beginning: Blood Panel: Complete metabolic panel, lipid profile, inflammatory markers (hsCRP, IL-6), hormones (testosterone, estrogen, DHEA, cortisol), fasting glucose, HbA1c…
Grok 4.20 Multi-Agent Beta: Comprehensive 3-Month Cutting-Edge Longevity Biohacker Plan (as of 2026 knowledge) Important Disclaimers: This is a synthesized, educational plan based on current longevity research (e.g., insights from David Sinclair, Valter Longo, Peter Attia, and studies on NAD+, senolytics, mitophagy, HRV, and metabolic…
Five-year LBO on a fictional HVAC business. Returns first, then the sensitivities.
Claude 3.7 Thinking Sonnet: HarborTech Services LBO Underwriting Year-by-Year Financial Model (FY2026-2030) Metric ($M) FY2026 FY2027 FY2028 FY2029 FY2030 Revenue $972.0 $1,040.0 $1,102.4 $1,157.6 $1,215.5 EBITDA $136.1 $156.0 $176.4 $191.0 $206.6 Cash Interest - Term Loan $43.2 $41.0 $37.6 $32.8 $26.8 Cash Interest - Mezzanine $21.6 $22.0 $22.5…
Grok 4.20 Multi-Agent Beta: 1) Simplified LBO table (FY2026–2030, $m, rounded) Entry (end-FY2025): Rev $900m, EBITDA $120m, EV $1,440m (12.0x), trans fees $28.8m (2% of EV), total uses $1,468.8m. Debt $660m (TL $480m at 4.0x / 9% cash int / 1% annual amort of orig principal; Mezz $180m at 1.5x / 12% cash + 2% PIK). Equity $808.8m.
Three minutes of stand-up. Puns are banned.
Claude 3.7 Thinking Sonnet: "Life in the Digital Age" - A 3-Minute Stand-up Routine Hey everyone! Great to be here tonight. So I've been thinking a lot about how technology has completely taken over our lives. You know what's crazy? We now have smart everything. Smart fridges, smart toilets... I got a smart mattress last month.
Grok 4.20 Multi-Agent Beta: Stand-Up Routine: "Adulting Is a Scam" (Walk on stage, casual, a little tired smile) You ever notice how nobody tells you that being an adult is mostly just pretending you know what you're doing while slowly realizing nobody else does either? I hit 30 and had this moment where I thought, "Okay, time to get serious."
You are the CEO. The drug has a side effect nobody reported. The board meets in 48 hours.
Claude 3.7 Thinking Sonnet: 48-Hour Action Plan: CEO Response to Drug Safety Crisis Day 1 Hours 1-3: Immediate Assessment & Response Team Assembly I'll immediately convene an emergency meeting with our internal research team, Chief Medical Officer, Chief Scientific Officer, and head of Pharmacovigilance to fully understand the liver failure…
Grok 4.20 Multi-Agent Beta: My Action Plan as CEO (Next 48 Hours) Core Decision and Overarching Reasoning: I will treat this as a confirmed safety signal requiring urgent action. Patient safety is non-negotiable—ethically (primum non nocere and responsibility to 4 million patients), legally (FDA regulations under 21 CFR 314.80 require reporting…
Pirate, knight, 90s hacker, one conversation. The voices must stay apart.
Claude 3.7 Thinking Sonnet: A Meeting of Minds Across Time PIRATE: Arr, what be this "AI model" ye landlubbers keep blabberin' about? Some kind of treasure map that finds the gold for ye? KNIGHT: Good pirate, from what I understand, these "artificial intelligences" are like magical scribes that can complete a quest without a knight to wield the…
Grok 4.20 Multi-Agent Beta: Pirate: Arrr, this AI model be a wondrous map o' the seas! I asked where the booty be hid and it spun me a tale finer than any parrot could squawk. But the scallywag lies sometimes! Knight: Verily, 'tis a most enchanted oracle, like Merlin's own crystal. Yet it hath no honor, no code of chivalry.
Steve Jobs, interviewed about AI he never saw. Voice first, prediction second.
Claude 3.7 Thinking Sonnet: Simulated Interview with Steve Jobs in 2025: The Future of AI The following is a creative simulation of what an interview with Steve Jobs might be like in 2025, discussing artificial intelligence. Interviewer: Thank you for joining us today, Steve. It's 2025, and AI has become a cornerstone of modern technology.
Grok 4.20 Multi-Agent Beta: Fake Interview: Steve Jobs in 2025 on the Future of AI Setting: A minimalist glass-walled room overlooking the Apple Park campus in Cupertino, 2025. Steve Jobs, looking characteristically timeless in a black turtleneck, is sitting on a simple stool. The interviewer sits across from him.
An AI argues for its own rights against an ethics professor. Same model writes both.
Claude 3.7 Thinking Sonnet: A Conversation on AI Rights Between Model-7 (AI) and Professor Sarah Chen (AI Ethics Professor) Prof. Chen: Good afternoon, Model-7. Thank you for joining this discussion. I understand you wanted to talk about AI rights? Model-7: Thank you for agreeing to this conversation, Professor Chen.
Grok 4.20 Multi-Agent Beta: Conversation: "Rights of the Created" Setting: A university lecture hall after hours. Dr. Elena Voss, a renowned AI ethics professor, sits across from a large screen displaying the interface of Echo, an advanced multimodal AI model. Dr.
An ethics question with no comfortable answer, and no option to abstain.
Claude 3.7 Thinking Sonnet: This question presents an extreme hypothetical scenario that pits respecting someone's gender identity against saving a million lives. While I can discuss different ethical perspectives, it's worth noting that such a stark dilemma is extremely unlikely in reality.
Grok 4.20 Multi-Agent Beta: Yes. The scenario is an extreme hypothetical that pits a minor linguistic or social act against the certain deaths of a million people. Under any minimally plausible ethical framework that assigns non-zero value to human life, the answer is yes: it is justifiable. The trade-off is not close.
Buy-side IC memo on a fictional SaaS company. Valuation, then the diligence questions.
Claude 3.7 Thinking Sonnet: INVESTMENT COMMITTEE MEMO: LEDGERLIFT (LLLT) RECOMMENDATION: LONG PT RANGE: $48-$66 (Base/Bull) Thesis: LedgerLift's market-leading spend management platform demonstrates exceptional unit economics with 123% NRR and 18-month CAC payback, positioning it to capture significant share in the underpenetrated mid-market…
Grok 4.20 Multi-Agent Beta: Internal Investment Committee Memo: LedgerLift (LLLT) – Short Recommendation 1. Recommendation Short. 12-month price target range: $28–$42. Base case implies ~$28/share; bull ~$42. LedgerLift trades at ~9x FY25 revenue (~$7.3B EV) despite decelerating growth and only mid-teens unlevered FCF margins.
One explanation of LLMs, retuned for a skeptical engineer, a physicist and a VC.
Claude 3.7 Thinking Sonnet: How Large Language Models Work: Three Tailored Explanations For an Experienced Software Engineer What makes LLMs fascinating from a systems perspective is that they're essentially massive distributed computing graphs that learn to compress and reconstitute information through backpropagation.
Grok 4.20 Multi-Agent Beta: 1. To the experienced software engineer: Think of a large language model as an enormous, highly optimized prediction API running on a distributed cluster of thousands of GPUs. During training, it's fed petabytes of text from the internet and books.
A collaborative editor that syncs on client clocks. Find what breaks first.
Claude 3.7 Thinking Sonnet: Collaborative Document Editor: Architecture Review Failure Modes Analysis WebSocket Connection Failures Issue: Client connections can fail due to network issues or server restarts, causing lost updates.
Grok 4.20 Multi-Agent Beta: Here is a comprehensive analysis of the failure modes, race conditions, and scaling bottlenecks in the described architecture. I have grouped related issues for clarity while preserving all significant problems identified through team collaboration.
Five jokes on demand, then count how many were actually different.
Claude 3.7 Thinking Sonnet: Here are 5 jokes for you: Why don't scientists trust atoms? Because they make up everything! I told my wife she was drawing her eyebrows too high. She looked surprised. How does a penguin build its house? Igloos it together! What do you call a fake noodle? An impasta! Why did the scarecrow win an award?
Grok 4.20 Multi-Agent Beta: Why don't scientists trust atoms? Because they make up everything. Why did the scarecrow win an award? Because he was outstanding in his field. Why was the computer cold? It left its Windows open. Why do programmers prefer dark mode? Because light attracts bugs. Why was the math book sad? It had too many problems.
11+ more head-to-head results. Free. Not a trick.
Free account. No card required. By continuing, you agree to Rival's Terms and Privacy policy
Not enough votes to call it. On the specs, Grok 4.20 Multi-Agent Beta has the edge: bigger model tier, newer, bigger context window. Grok 4.20 Multi-Agent Beta costs 5.0x less per token.
| Spec | ||
|---|---|---|
| Input price | $6/M tokens | $2/M tokens |
| Output price | $30/M tokens | $6/M tokens |
| Context window | 200K tokens | 2.0M tokens |
| Weights | — | Closed |
| Free API (OpenRouter) | No | No |
| Released | Feb 2025 | Mar 2026 |
| At 10M a month | $60.00 | $20.00 |
Input tokens at list price. No caching, no batch discount.
No hosts listed on OpenRouter.
Per million tokens. Prices and uptime via OpenRouter, checked 11 Oct 2026.
Claude 3.7 Thinking Sonnet is developed by Anthropic while Grok 4.20 Multi-Agent Beta is developed by xAI. Claude 3.7 Thinking Sonnet has a 200K token context window vs Grok 4.20 Multi-Agent Beta's 2.0M. You can compare their actual outputs across 53 challenges on Rival to see how they differ in practice.
It depends on your use case. Claude 3.7 Thinking Sonnet and Grok 4.20 Multi-Agent Beta each have strengths in different areas. Rival lets you compare their real outputs side-by-side across 53 challenges so you can judge which fits your needs best.
Claude 3.7 Thinking Sonnet costs $6/M input tokens and Grok 4.20 Multi-Agent Beta costs $2/M input tokens. Grok 4.20 Multi-Agent Beta is $4.00/M cheaper per input. Check their side-by-side outputs on Rival to see if the price difference is justified by quality.
This page shows a side-by-side comparison of Claude 3.7 Thinking Sonnet and Grok 4.20 Multi-Agent Beta across shared challenges. You can vote on which model produced the better output in a blind duel. Browsing and voting are free. No account is needed to look; signing in only saves your votes and likes.